Pfizer Announces Top-Line Results of ABRYSVO® for RSV in Immunocompromised Adults

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. GOOGL
5. MU
6. USO
7. APGE
8. ABBV
9. MSFT
10. IBM

Go back to Pfizer Announces Top-Line Results of ABRYSVO® for RSV in Immunocompromised Adults
Pfizer Inc. (NYSE: PFE) Delayed: 25.08 --0 (-0%)
Previous Close $25.08    52 Week High $37.39 
Open $25.08    52 Week Low $28.25 
Day High $25.08    P/E 15.20 
Day Low $25.08    EPS $1.65 
Volume 144,156       

Pfizer Inc. (NYSE: PFE) Delayed: 25.08 --0 (-0%)
Previous Close $25.08    52 Week High $37.39 
Open $25.08    52 Week Low $28.25 
Day High $25.08    P/E 15.20 
Day Low $25.08    EPS $1.65 
Volume 144,156